Close Menu
New York Examiner News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Robert Pattinson Cast as the Next James Bond

    November 16, 2026

    US tightens AI chip export controls to deter Chinese companies from accessing compute remotely | TechCrunch

    November 16, 2026

    Garrick Merrifield Resurfaces With AI Harem Of Wives, Cult Vibes

    November 16, 2026
    Facebook X (Twitter) Instagram
    New York Examiner News
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    New York Examiner News
    Home»Science»People with Long COVID May Still Have Spike Proteins in Their Blood
    Science

    People with Long COVID May Still Have Spike Proteins in Their Blood

    By AdminJuly 21, 2022
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    People with Long COVID May Still Have Spike Proteins in Their Blood

    [ad_1]

    The now infamous condition long COVID presents as a wide range of symptoms—everything from persistent chest pains to rashes, pins and needles, and brain fog. Doctors can diagnose long COVID by speaking to their patients about their experiences before and after an initial COVID infection, but researchers still haven’t pinned down what causes the condition or how to treat it. Part of the difficulty is that there isn’t yet a way to measure biological signals of long COVID infections in the body to start the process of testing new treatments. Now researchers may have found a marker for the disabling condition: a piece of SARS-CoV-2, the virus that causes COVID, floating around in the blood of some long COVID sufferers well after their initial infection.

    In a preprint paper uploaded to medRxiv in June, researchers reported detecting a fragment of SARS-CoV-2 in blood samples from long COVID sufferers up to a year after their original infection. The fragment is a spike protein, one of the protrusions around the outside of SARS-CoV-2 that give this coronavirus its namesake corona, or crownlike appearance. During an initial COVID infection, the spike protein typically breaks off into smaller pieces when it penetrates human cells, but the spike proteins observed in this study were still in one piece. The findings have not yet been peer-reviewed.

    The researchers searched for the spike protein by using a technique designed for identifying individual proteins. They added microscopic beads covered in antibodies to blood plasma from 37 people who had been diagnosed with long COVID. The samples were taken two or more times over the course of a year since the patients’ original COVID infection and compared with plasma from a control group of 26 people who had fully recovered from the disease. The beads light up when they come into contact with the specific protein that binds to the antibody in their coating. The presence and intensity of the change can be used to tell both that the sought-after protein is present and how much of it there is.

    The intact spike protein found in patients’ blood could indicate that infected cells missed by the immune system are to blame for long COVID. “Our main hypothesis is that [the spike protein is] not causing the symptoms, but it’s just a marker that is released because you still have infection of some cells with SARS-CoV-2,” says study co-author Zoe Swank, a research scientist at Brigham and Women’s Hospital in Boston.

    When a cell is infected with a virus such as SARS-CoV-2, the pathogen makes copies of itself within the cell. If the cell dies, it bursts, potentially releasing intact spike proteins into the blood. Cells can also shed small packages of proteins and other materials such as viral particles wrapped in a layer of cell membrane. These are known as “extracellular vesicles,” and they could be another way for the spike protein to get into the blood stream without breaking up. Either way, these mechanisms require a reservoir of the virus somewhere in the body.

    “If you had an infection, and you cleared it, then normally, you would not see [the spike protein] because all the antibodies you produced would clear everything that enters the bloodstream,” Swank says. Instead, she suggests, tissues such as those in the gut and brain could be a haven for SARS-CoV-2 within the body, preventing long COVID patients from fully clearing their infections and acting as a source of spike proteins. “Maybe the virus can just persist there. It evades the immune system somehow.”

    This hypothesis lines up with other evidence that COVID infects more parts of the body than just the lungs, including studies that have found SARS-CoV-2 in deceased patients’ organs. This preprint study doesn’t rule out other possible causes of long COVID, however, particularly because not all of the long COVID sufferers had the spike protein in their blood.

    “The presence of circulating viral proteins may be helpful to identify which subset of long COVID patients might have the persistent viral etiology”—the version of long COVID caused by the ongoing presence of SARS-CoV-2 in the body—says Akiko Iwasaki, an immunologist at Yale University, who was not involved with the study. “The rest of the long haulers might suffer from other causes.” These other causes could include an overblown immune response that leads COVID patients’ body to develop immune proteins—“autoantibodies”—that attack its own cells in the same way they would attack an intruder such as a virus or bacterium. These autoantibodies have been found in people’s body during an initial COVID infection, as well as in the bodies of some long COVID patients. Another possibility is that a COVID infection makes people more susceptible to other viruses already present in the body, such as the Epstein-Barr virus. This pathogen lies dormant in most people but has been found reactivated in some long COVID patients.

    For Swank, the most promising part of the new study is that the intact spike protein signal was only observed in samples from people who were diagnosed with long COVID two to 12 months after first getting sick with COVID and not in patients who only experienced an initial infection. The finding hints that this spike protein found in the blood could be a “biomarker,” specifically for long COVID.

    “This study, to me, is potentially a game changer, if it’s confirmed,” says infectious disease physician-scientist Michael Peluso of the University of California, San Francisco, who was not involved in the study. “One of the major obstacles to designing and implementing studies of treatments for long COVID is that, while we can ask people how they feel, there has not so far been a clear, objective marker that is measurable in the blood of people experiencing long COVID.”

    Scientists would be able to measure the amount of a reliable biomarker present in the blood of a patient before and after administering medications such as antivirals. If the amount of that biomarker decreases, it could indicate the treatment is working. “It’s been quite challenging to mobilize resources to implement treatment studies for long COVID, even though everybody is in agreement that they are necessary,” Peluso says. “Identifying biomarkers of disease activity would likely make it much more feasible to get those studies going.”

    There is still a long road ahead, however. The preprint is still awaiting peer review, and it only looks at a small sample of long COVID sufferers diagnosed at the same hospital, most of whom were female. Additionally, the researchers didn’t have access to blood samples more than five months after an initial COVID infection for patients who didn’t have long COVID.

    Confirming the results will require analyzing blood samples from a larger, more representative group of long COVID sufferers and comparing them with blood samples from people who have fully recovered from COVID that were collected months and years after their initial infection. In the future, Swank and her co-authors hope to use blood samples collected over the course of the pandemic from multiple hospitals to scale up their study to hundreds of people.

    “I hope that their findings will hold up,” Peluso says. “It really would, I think, make a difference for a lot of people if a marker like this could be validated.”

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous Article15 Most Powerful She-Hulk Villains
    Next Article Google Pixel 6A Review: Heaps of Power, but With a Few Flaws

    RELATED POSTS

    Climate Change Has Pushed the World's Ice Out of Its Safe Zone

    November 12, 2026

    Synchron Pauses Trials of Its Brain Implant Due to Performance Issues

    November 12, 2026

    The Polar Vortex Is About to Make Weather Weird From the UK to the US

    November 12, 2026

    A Startup Wants to Fight AI Bioweapons With AI

    November 11, 2026

    Michigan Residents Voted to Get Corporate Money Out of Politics. Now Utilities Are Suing

    November 11, 2026

    A New Benchmark for De-Aging Comes From Slowly Turning Back Cells Clocks

    November 11, 2026
    latest posts

    Robert Pattinson Cast as the Next James Bond

    After literal years of speculation and dozens of names being mentioned, director Denis Villeneuve has…

    US tightens AI chip export controls to deter Chinese companies from accessing compute remotely | TechCrunch

    November 16, 2026

    Garrick Merrifield Resurfaces With AI Harem Of Wives, Cult Vibes

    November 16, 2026

    Karol G Postpones Show in Mexico City Due to Health Reasons: Heres the New Date

    November 16, 2026

    Angels & Demons: Ken Russell's The Devils

    November 15, 2026

    Where was Nvidias security team? | TechCrunch

    November 15, 2026

    6 Golden Age Westerns To Watch On Prime Video (That Dont Star John Wayne)

    November 15, 2026
    Categories
    • Books (1,590)
    • Business (6,481)
    • Events (85)
    • Film (6,450)
    • Lifestyle (4,502)
    • Music (6,583)
    • Politics (6,447)
    • Science (5,851)
    • Technology (6,438)
    • Television (6,142)
    • US News (6,486)
    popular posts

    UK union staged 24-hour strike in response to Uber files leak – TechCrunch

    [ad_1] The UK’s App Drivers and Couriers Union (ADCU) staged a 24-hour strike Wednesday to…

    A Top Senate Republican Is Livid After Getting Outwitted By Manchin And Schumer

    July 29, 2022

    Tesla’s Berlin Hub Can’t Hire Enough People, or Keep Them

    December 5, 2022

    ‘Sister Wives’ Christine Brown Claims Robyn Plotted Against Meri

    January 1, 2025
    Archives
    Browse By Category
    • Books (1,590)
    • Business (6,481)
    • Events (85)
    • Film (6,450)
    • Lifestyle (4,502)
    • Music (6,583)
    • Politics (6,447)
    • Science (5,851)
    • Technology (6,438)
    • Television (6,142)
    • US News (6,486)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    Where was Nvidias security team? | TechCrunch

    November 15, 2026

    6 Golden Age Westerns To Watch On Prime Video (That Dont Star John Wayne)

    November 15, 2026

    Watch Travis Barker and Cynthia Erivo perform In The Air Tonight as Phil Collins tells Rock & Roll Hall Of Fame: You havent heard the last of me

    November 15, 2026
    © 2026 New York Examiner News. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT